In the run-up to the 2026 midterm elections, the political parties in many states are working to redefine their congressional district maps to gain every possible edge. From California and Texas to Tennessee and Virginia, redistricting efforts have taken center stage. The Supreme Court has sanctioned partisan gerrymandering, and the system has evolved to one in which state legislature majorities get to determine who is most likely to fill those seats in Congress.
In short, gerrymandering has become a central feature of the system, not a bug. But what if we rethink the structure entirely?
For years, remote work has been viewed as one of the most important drivers of employee satisfaction. New research suggests that assumption may be giving remote work too much credit.
A study published in the INFORMS journal Management Science found that while remote employees often report higher job satisfaction, much of that advantage disappears when researchers account for factors such as workplace culture, trust in management, communication and opportunities for professional development.
A new study from INFORMS suggests warehouse robots perform better when they work together instead of operating independently.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
We have just a few weeks to plan for our best and possibly only way to stop this pandemic before it destroys our economy and health care system.
What-if questions can torment a doctor making coronavirus retest decisions: What if a patient’s initial negative test was a false negative, and he or she needs a second test? What if they don’t need it, and a retest would use up a scarce test kit and treatments that other patients need?
Abbott will deliver 50,000 COVID-19 tests per day to healthcare workers, starting Wednesday, using its modified ID NOW testing process, it said. Bringing rapid coronavirus testing capacity to the medical front lines is crucial in the battle to flatten the rising death and infection curve worldwide.
Gilead has asked the Food and Drug Administration to rescind a special regulatory status for its experimental coronavirus drug, but not before stirring up a controversy that had critics accusing the company of manipulating a law designed to spur research into therapies for rare diseases.
Even as the business climate remains deeply unpredictable, supply chain leaders should act now to plot their comebacks.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine